Logo image of IBO.CA

UNIVERSAL IBOGAINE INC (IBO.CA) Stock Price, Forecast & Analysis

Canada - TSX Venture Exchange - TSX-V:IBO - CA91360F1099 - Common Stock

0.005 CAD
0 (0%)
Last: 12/31/2025, 7:00:00 PM

IBO.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap1.56M
Revenue(TTM)2.06M
Net Income(TTM)-1.48M
Shares312.86M
Float270.81M
52 Week High0.05
52 Week Low0.01
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.01
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2017-06-21
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


IBO.CA short term performance overview.The bars show the price performance of IBO.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

IBO.CA long term performance overview.The bars show the price performance of IBO.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of IBO.CA is 0.005 CAD. In the past year, price decreased by -50%.

UNIVERSAL IBOGAINE INC / IBO Daily stock chart

About IBO.CA

Company Profile

IBO logo image Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The firm is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which, paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. The company is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for about 1-4 months, associated with elimination of addictive cravings.

Company Info

UNIVERSAL IBOGAINE INC

(c/o Suite 600 - 815 8th Avenue SW

Calgary ALBERTA CA

Employees: 0

IBO Company Website

IBO Investor Relations

Phone: 14038701841.0

UNIVERSAL IBOGAINE INC / IBO.CA FAQ

What does UNIVERSAL IBOGAINE INC do?

Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The firm is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which, paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. The company is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for about 1-4 months, associated with elimination of addictive cravings.


What is the current price of IBO stock?

The current stock price of IBO.CA is 0.005 CAD.


Does IBO stock pay dividends?

IBO.CA does not pay a dividend.


What is the ChartMill rating of UNIVERSAL IBOGAINE INC stock?

IBO.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


What is the market capitalization of IBO stock?

UNIVERSAL IBOGAINE INC (IBO.CA) has a market capitalization of 1.56M CAD. This makes IBO.CA a Nano Cap stock.


IBO.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

IBO.CA Financial Highlights

Over the last trailing twelve months IBO.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 22.39% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -36.85%
ROE -542.4%
Debt/Equity 6.33
Chartmill High Growth Momentum
EPS Q2Q%93.33%
Sales Q2Q%30.59%
EPS 1Y (TTM)22.39%
Revenue 1Y (TTM)-11.69%

IBO.CA Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

IBO.CA Ownership

Ownership
Inst OwnersN/A
Ins Owners13.44%
Short Float %N/A
Short RatioN/A